Meta-analysis: Angiotensin receptor blockers linked to modest increase in risk ... - HemOncToday Print
HemOncToday“However, clinical trials of ARBs have mainly assessed their effects on cardiovascular and renal endpoints and have usually not reported incidence of

... read more